MedPath

Clinical Evaluation of Two Daily Disposable Lenses in Neophytes

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: nelfilcon A contact lens
Device: narafilcon A contact lens
Registration Number
NCT00987623
Lead Sponsor
CIBA VISION
Brief Summary

The purpose of this study is to evaluate the performance of two daily disposable contact lenses in a population of neophytes (new wearers).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
326
Inclusion Criteria
  • No previous contact lens experience or attempts to try contact lenses (neophytes).
  • Currently wearing spectacles or needing vision correction in both eyes.
  • No older than 45 years of age.
  • Able to achieve visual acuity of at least 20/40 in each eye with study lenses in the available parameters.
  • Interested in wearing contact lenses.
  • Willing to wear study lenses for at least 8 hours/day, at least 5 days/week.
  • Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion Criteria
  • Eye injury or surgery within twelve weeks prior to enrollment.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Previous corneal or refractive surgery.
  • Currently enrolled in any Clinical Trial.
  • Other protocol-defined inclusion/exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nelfilcon Anelfilcon A contact lensCommercially marketed contact lens worn in both eyes on a daily wear, daily disposable basis for one week.
narafilcon Anarafilcon A contact lensCommercially marketed contact lens worn in both eyes on a daily wear, daily disposable basis for one week.
Primary Outcome Measures
NameTimeMethod
Overall Lens Satisfaction1 week

Overall Lens Satisfaction, as interpreted by the participant and reported on a questionnaire as a single, retrospective evaluation of 1-week's wear time. Overall lens satisfaction was measured on a 10-point scale, with 1 being Poor and 10 being Excellent

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Research Intelligence Group (TRiG)

🇺🇸

Fort Washington, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath